TADA Certificate Program

Overview: 

  • Offers TADA courses and most of the professional development activities offered by the fellowship.
  • Can be started at any point during PhD candidacy.

Eligibility:

  • Open to PhD students – in good standing – from any Emory department or degree program.
  • Applicants must be prepared to engage in interdisciplinary collaboration and learning multiple software packages used to analyze big data.
  • Applicants demonstrate interest in learning and applying advanced data science analytics to end drug-related harms. 

Students in the TADA Certificate Program are required to participate in the following training activities:

1. Required Courses (Click here for details on all TADA Courses)

BSHES 735 TADA: Reducing Drug-Related Harms Using “Big Data”: Administrative, Geospatial & Network Sources 3 credits, Spring Semester
BSHES 740 TADA: Reducing Drug-Related Harms Using Internet-Based “Big Data”: Machine Learning and AI Methods 3 credits, Fall Semester
BSHES 745 TADA: Professional Development, Current Topics and Dissertation Workshop course  1 credit/semester, 4 total required
Two advanced, graduate-level courses in chosen track, approved on case-by-case basis by TADA leadership. (Tracks include: Geospatial Analysis; Analyzing large administrative databases; Machine Learning; Genetic and Environmental Influences and Interactions; Social networks) Min. 4 credits (2 credits each) required

 


2. Individual Development Plan (IDP) and Mentor Matching

  • TADA Fellows are required to set academic and professional goals for his/her fellowship training.
  • IDP is part of the fellow’s professional responsibility to chart goals and success in the TADA program and assist with ensuring timely progress.
  • Access to mentors through TADA faculty network.

3. Training in Menteeship


4. Professional Development Opportunities

  • “Journal Club Unplugged” Sessions
  • Seminars
  • Research Symposium

  5. Dissertation Submission

  • At least One Aim must focus on big data science + One (or same) Aim on a drug-related outcome.